Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide

ClinicalTrials.gov ID: NCT02638805

Public ClinicalTrials.gov record NCT02638805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 12:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Center, Randomized, Phase 3b Study to Evaluate the Safety and Tolerability of Switching to One of Two Dosing Strategies of ITCA 650 in Patients With Type 2 Diabetes Receiving Stable Doses of Liraglutide

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3b, open-label, randomized, multicenter, safety and tolerability study of ITCA 650 in subjects with Type 2 diabetes taking liraglutide and metformin.

Study identification

NCT ID
NCT02638805
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Intarcia Therapeutics
Industry
Enrollment
136 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Sep 30, 2017
Completion
Sep 30, 2017
Last update posted
Nov 4, 2018

2015 – 2017

United States locations

U.S. sites
36
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235
Saint Vincent's Medical Center (BRANY) Gulf Shores Alabama 36542
Arkansas Primary Care Clinic, PA Little Rock Arkansas 72204
University of Colorado Hospital Aurora Colorado
Denver VA Medical Center Denver Colorado 80220
Meridien Research Brooksville Florida 34601
International Research Associates, LLC Hialeah Florida 33012
Care Partners Clinical Research, LLC Jacksonville Florida 32218
AMPM Research Clinic Miami Florida 33145
Epocrates Medical and Research Center Miami Florida 33175
Sensible Healthcare, LLC Ocoee Florida 34761
Solaris Clinical Research Meridian Idaho 83646
American Health Network of Indiana, LLC Avon Indiana 46123
American Health Network of Indiana, LLC Franklin Indiana 46131
American Health Network of Indiana, LLC Greenfield Indiana 46140
Cotton-O'Neil Clinical Research Center Topeka Kansas 66606
University of Massachusetts Medical School Worcester Massachusetts 01655
Center for Advanced Medical Research City of Saint Peters Missouri 63303
Radiant Research St Louis Missouri 63141
Accent Clinical Trials Las Vegas Nevada 89119
Palm Research Center, Inc. Las Vegas Nevada 89148
Manhattan Medical Research New York New York 10016
Novel Research of New York The Bronx New York 10461
Carteret Medical Group, LLC Morehead City North Carolina 28557
Prestige Clinical Research Franklin Ohio 45005
Lynn Institute of the Oz Norman Oklahoma 73069
LION Research Norman Oklahoma 73072
University of Tennessee Health Sciences Center Memphis Tennessee 38103
Coastal Bend Clinical Research Corpus Christi Texas 78414
Dallas Diabetes and Endocrine Center Dallas Texas 75230
Juno Research, LLC Houston Texas 77036
Sante Clinical Research Kerrville Texas 78028
Panacea Clinical Research, LLC San Antonio Texas 78228
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Victorium Clinical Research Ltd. San Antonio Texas 78229
Erickson Research and Development Clinton Utah 84015

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02638805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2018 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02638805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →